195 related articles for article (PubMed ID: 17239472)
1. Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier.
Kratzer I; Wernig K; Panzenboeck U; Bernhart E; Reicher H; Wronski R; Windisch M; Hammer A; Malle E; Zimmer A; Sattler W
J Control Release; 2007 Feb; 117(3):301-11. PubMed ID: 17239472
[TBL] [Abstract][Full Text] [Related]
2. Afamin is synthesized by cerebrovascular endothelial cells and mediates alpha-tocopherol transport across an in vitro model of the blood-brain barrier.
Kratzer I; Bernhart E; Wintersperger A; Hammer A; Waltl S; Malle E; Sperk G; Wietzorrek G; Dieplinger H; Sattler W
J Neurochem; 2009 Feb; 108(3):707-18. PubMed ID: 19046407
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein imitating nanoparticles: Lecithin coating binds ApoE and mediates non-lysosomal uptake leading to transcytosis over the blood-brain barrier.
Wünsch A; Mulac D; Langer K
Int J Pharm; 2020 Nov; 589():119821. PubMed ID: 32861770
[TBL] [Abstract][Full Text] [Related]
4. Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model.
Balazs Z; Panzenboeck U; Hammer A; Sovic A; Quehenberger O; Malle E; Sattler W
J Neurochem; 2004 May; 89(4):939-50. PubMed ID: 15140193
[TBL] [Abstract][Full Text] [Related]
5. Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration.
Scheicher B; Lorenzer C; Gegenbauer K; Partlic J; Andreae F; Kirsch AH; Rosenkranz AR; Werzer O; Zimmer A
PLoS One; 2016; 11(11):e0164149. PubMed ID: 27828968
[TBL] [Abstract][Full Text] [Related]
6. Comparison of PEGylated and non-PEGylated proticles: An in vitro and in vivo study.
Fresacher K; Helbok A; Reiser M; Blass S; Rangger C; Mair C; von Guggenberg E; Decristoforo C; Andreae F; Zimmer A
Eur J Pharm Sci; 2019 Nov; 139():105063. PubMed ID: 31487537
[TBL] [Abstract][Full Text] [Related]
7. Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles.
Wernig K; Griesbacher M; Andreae F; Hajos F; Wagner J; Mosgoeller W; Zimmer A
J Control Release; 2008 Sep; 130(2):192-8. PubMed ID: 18601963
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties, and intracellular distribution.
Vogel V; Lochmann D; Weyermann J; Mayer G; Tziatzios C; van den Broek JA; Haase W; Wouters D; Schubert US; Kreuter J; Zimmer A; Schubert D
J Control Release; 2005 Mar; 103(1):99-111. PubMed ID: 15710504
[TBL] [Abstract][Full Text] [Related]
9. Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting.
Scheicher B; Schachner-Nedherer AL; Zimmer A
Eur J Pharm Sci; 2015 Jul; 75():54-9. PubMed ID: 25896372
[TBL] [Abstract][Full Text] [Related]
10. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes.
Gaillard PJ; Voorwinden LH; Nielsen JL; Ivanov A; Atsumi R; Engman H; Ringbom C; de Boer AG; Breimer DD
Eur J Pharm Sci; 2001 Jan; 12(3):215-22. PubMed ID: 11113640
[TBL] [Abstract][Full Text] [Related]
11. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated transcytosis of macromolecules across the blood-brain barrier.
Baghirov H
Expert Opin Drug Deliv; 2023; 20(12):1699-1711. PubMed ID: 37658673
[TBL] [Abstract][Full Text] [Related]
13. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation.
Lu W; Tan YZ; Jiang XG
Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472
[TBL] [Abstract][Full Text] [Related]
14. Effects of lipoprotein lipase on uptake and transcytosis of low density lipoprotein (LDL) and LDL-associated alpha-tocopherol in a porcine in vitro blood-brain barrier model.
Goti D; Balazs Z; Panzenboeck U; Hrzenjak A; Reicher H; Wagner E; Zechner R; Malle E; Sattler W
J Biol Chem; 2002 Aug; 277(32):28537-44. PubMed ID: 12032155
[TBL] [Abstract][Full Text] [Related]
15. Lecithin coating as universal stabilization and functionalization strategy for nanosized drug carriers to overcome the blood-brain barrier.
Wünsch A; Mulac D; Langer K
Int J Pharm; 2021 Jan; 593():120146. PubMed ID: 33279714
[TBL] [Abstract][Full Text] [Related]
16. The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells.
Abulrob A; Sprong H; Van Bergen en Henegouwen P; Stanimirovic D
J Neurochem; 2005 Nov; 95(4):1201-14. PubMed ID: 16271053
[TBL] [Abstract][Full Text] [Related]
17. Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.
Simonneau C; Duschmalé M; Gavrilov A; Brandenberg N; Hoehnel S; Ceroni C; Lassalle E; Kassianidou E; Knoetgen H; Niewoehner J; Villaseñor R
Fluids Barriers CNS; 2021 Sep; 18(1):43. PubMed ID: 34544422
[TBL] [Abstract][Full Text] [Related]
18. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier.
Lu W; Tan YZ; Hu KL; Jiang XG
Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009
[TBL] [Abstract][Full Text] [Related]
19. Protamine nanoparticles with CpG-oligodeoxynucleotide prevent an allergen-induced Th2-response in BALB/c mice.
Pali-Schöll I; Szöllösi H; Starkl P; Scheicher B; Stremnitzer C; Hofmeister A; Roth-Walter F; Lukschal A; Diesner SC; Zimmer A; Jensen-Jarolim E
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):656-64. PubMed ID: 23523543
[TBL] [Abstract][Full Text] [Related]
20. Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E.
Goti D; Hrzenjak A; Levak-Frank S; Frank S; van der Westhuyzen DR; Malle E; Sattler W
J Neurochem; 2001 Jan; 76(2):498-508. PubMed ID: 11208913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
